These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 7612698)
61. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector. Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039 [TBL] [Abstract][Full Text] [Related]
62. DNA inoculation induces protective in vivo immune responses against cellular challenge with HIV-1 antigen-expressing cells. Wang B; Merva M; Dang K; Ugen KE; Boyer J; Williams WV; Weiner DB AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S35-41. PubMed ID: 7865331 [TBL] [Abstract][Full Text] [Related]
63. A carcinoembryonic antigen polynucleotide vaccine for human clinical use. Conry RM; LoBuglio AF; Loechel F; Moore SE; Sumerel LA; Barlow DL; Pike J; Curiel DT Cancer Gene Ther; 1995 Mar; 2(1):33-8. PubMed ID: 7621253 [TBL] [Abstract][Full Text] [Related]
65. Immunization by direct DNA inoculation induces rejection of tumor cell challenge. Wang B; Merva M; Dang K; Ugen KE; Williams WV; Weiner DB Hum Gene Ther; 1995 Apr; 6(4):407-18. PubMed ID: 7612698 [TBL] [Abstract][Full Text] [Related]
66. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy. Hwang C; Sanda MG Curr Opin Mol Ther; 1999 Aug; 1(4):471-9. PubMed ID: 11713762 [TBL] [Abstract][Full Text] [Related]
67. Regulatory issues in the use of DNA vaccines. Minor PD Ann N Y Acad Sci; 1995 Nov; 772():170-7. PubMed ID: 8546390 [No Abstract] [Full Text] [Related]